• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Republica Press

Your Business & Political News Source

REPUBLICA PRESS
Your Business & Political News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • SCIENCE/TECH
  • US
  • WORLD
  • VIDEOS

J.&.J. Vaccine Will Be Available Again Soon

by

Up until just hours before the pause was recommended by American officials, regulators had planned for a revision to the F.D.A.’s emergency use authorization similar to the one formalized Friday, with warnings about the blood clots.

But top health officials decided in a meeting on April 12 that the government should call for a pause while federal authorities and the C.D.C.’s expert panel investigated a possible link between the clots and the vaccine. They feared a number of cases of the disorder had not been identified and wanted to allow more time for those who had just received the vaccine to reach the point at which the rare clotting typically appears.

“As we did this intensive scientific evaluation over recent days, I think we became more and more confident about the decision that was made today,” Dr. Janet Woodcock, the acting F.D.A. commissioner, said on Friday.

In the C.D.C. panel analysis, women between 30 and 39 appear to be at greatest risk, with 11.8 cases per million doses given. Among women 18 to 49, there have been seven cases per million doses. The condition, which the C.D.C. is calling thrombosis with thrombocytopenic syndrome, causes severe blood clots and also a tendency to bleed at the same time, because of abnormally low levels of platelets, a blood component involved in clotting.

The disorder is “rare but clinically serious,” Dr. Tom Shimabukuro, the deputy director of the C.D.C.’s immunization safety office, said at the meeting.

Additional potential cases, including some in men, are being reviewed. There was also a case in a 25-year-old man who participated in a clinical trial of the vaccine.

The patients’ symptoms closely resemble a rare syndrome that can be caused by heparin, a widely used blood thinner, Dr. Michael Streiff, a hematologist at Johns Hopkins University, told the panel. Heparin, typically used to treat blood clots, should not be given to these patients, he said.

View Source

Filed Under: BUSINESS Tagged With: Advisory Committee on Immunization Practices, Blood, Blood Clots, Centers for Disease Control and Prevention, Coronavirus (2019-nCoV), Government, Health, Heparin (Drug), Regulators, safety, Women, Women and Girls, your-feed-healthcare

Primary Sidebar

More to See

Three Men Charged in Prison Killing of Whitey Bulger

Three men were indicted in the death of the notorious gangster James (Whitey) Bulger, who was beaten to death four years ago in a West Virginia … [Read More...] about Three Men Charged in Prison Killing of Whitey Bulger

Home Appraised With a Black Owner: $472,000. With a White Owner: $750,000.

Dr. Connolly and Dr. Mott live in the North Baltimore neighborhood of Homeland, known for its strong public schools and colonial architecture, which … [Read More...] about Home Appraised With a Black Owner: $472,000. With a White Owner: $750,000.

JLC LIVE Announces First-Ever ‘Next Live’ Presenter Contest, Offering Skilled Construction Professionals the Opportunity to Compete for a Leading Voice in the Industry and a Cash Prize

PROVIDENCE, R.I.--(BUSINESS WIRE)--Informa Markets' JLC LIVE Residential Construction Show today announced the launch of its Next Live Presenter … [Read More...] about JLC LIVE Announces First-Ever ‘Next Live’ Presenter Contest, Offering Skilled Construction Professionals the Opportunity to Compete for a Leading Voice in the Industry and a Cash Prize

Copyright © 2022 · Republica Press · Log in · As an Amazon Associate we earn from qualifying purchases.

Terms and Conditions - Privacy Policy